联影医疗
(688271)
| 流通市值：785.06亿 | | | 总市值：1092.50亿 |
| 流通股本：5.92亿 | | | 总股本：8.24亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,350,478,362.11 | 11,410,765,602.39 | 7,432,439,187.03 | 5,271,345,801.64 |
| 营业收入 | 2,350,478,362.11 | 11,410,765,602.39 | 7,432,439,187.03 | 5,271,345,801.64 |
| 二、营业总成本 | 2,055,132,564.46 | 9,857,946,495.53 | 6,729,976,932.09 | 4,575,991,944.56 |
| 营业成本 | 1,185,383,044.59 | 5,878,580,949.27 | 3,815,268,811.05 | 2,703,489,492.74 |
| 税金及附加 | 11,871,069.33 | 69,491,966.37 | 46,884,215.56 | 34,152,460.94 |
| 销售费用 | 357,708,220.26 | 1,769,512,581.9 | 1,253,133,703.68 | 824,042,437.32 |
| 管理费用 | 121,179,166.33 | 560,706,672.14 | 379,972,762.69 | 246,597,030.31 |
| 研发费用 | 419,681,857.09 | 1,728,541,428.81 | 1,369,570,294.31 | 885,230,940.23 |
| 财务费用 | -40,690,793.14 | -148,887,102.96 | -134,852,855.2 | -117,520,416.98 |
| 其中:利息费用 | 703,529.22 | 7,022,227.79 | 5,229,503.61 | 3,433,414.86 |
| 其中:利息收入 | -39,208,006.08 | -174,671,675.38 | -143,991,837.43 | -101,269,719.74 |
| 加:公允价值变动收益 | 7,802,116.67 | -6,062,747.97 | -5,542,564.44 | -7,048,964.54 |
| 加:投资收益 | 15,500,994.89 | 110,345,129.18 | 81,211,919.13 | 48,874,967.91 |
| 资产处置收益 | - | 13,463.47 | 13,463.48 | 13,463.48 |
| 资产减值损失(新) | 2,079,721.71 | -42,886,067.58 | -4,587,497.09 | 1,320,633.73 |
| 信用减值损失(新) | -25,584,071.83 | -58,982,635.1 | 1,428,254.13 | 34,809,477.38 |
| 其他收益 | 105,262,737.48 | 586,268,985.13 | 388,823,505.17 | 273,096,753.08 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 400,407,296.57 | 2,141,515,233.99 | 1,163,809,335.32 | 1,046,420,188.12 |
| 加:营业外收入 | 950,369.97 | 10,533,540.14 | 10,630,383.24 | 8,267,060.65 |
| 减:营业外支出 | 1,617,125.62 | 9,794,100.22 | 8,003,893.16 | 7,405,493.29 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 399,740,540.92 | 2,142,254,673.91 | 1,166,435,825.4 | 1,047,281,755.48 |
| 减:所得税费用 | 37,798,169.16 | 164,499,867.47 | 100,871,131 | 107,584,296.64 |
| 六、净利润 | 361,942,371.76 | 1,977,754,806.44 | 1,065,564,694.4 | 939,697,458.84 |
| 持续经营净利润 | 361,942,371.76 | 1,977,754,806.44 | 1,065,564,694.4 | 939,697,458.84 |
| 归属于母公司股东的净利润 | 363,297,720.56 | 1,974,292,317.49 | 1,064,287,220.09 | 937,776,940.87 |
| 少数股东损益 | -1,355,348.8 | 3,462,488.95 | 1,277,474.31 | 1,920,517.97 |
| (一)基本每股收益 | 0.44 | 2.4 | 1.29 | 1.14 |
| (二)稀释每股收益 | 0.44 | 2.4 | 1.29 | 1.14 |
| 八、其他综合收益 | 1,045,318.26 | 13,750,597.25 | 5,031,393.16 | 12,738,931.36 |
| 归属于母公司股东的其他综合收益 | 1,045,318.26 | 13,750,597.25 | 5,031,393.16 | 12,738,931.36 |
| 九、综合收益总额 | 362,987,690.02 | 1,991,505,403.69 | 1,070,596,087.56 | 952,436,390.2 |
| 归属于母公司股东的综合收益总额 | 364,343,038.82 | 1,988,042,914.74 | 1,069,318,613.25 | 950,515,872.23 |
| 归属于少数股东的综合收益总额 | -1,355,348.8 | 3,462,488.95 | 1,277,474.31 | 1,920,517.97 |
| 公告日期 | 2024-04-27 | 2024-04-27 | 2023-10-28 | 2023-08-19 |
| 审计意见(境内) | | 标准无保留意见 | | |